Medication info
Janical Tablet (Risedronate Sodium 2.5 Hydrate)

Janical Tablet (Risedronate Sodium 2.5 Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›172.1mg / 1 tablet
Manufacturer / importer
Samnam Pharmaceutical Co., Ltd.
Appearance
Bright blue oval film-coated tablet
Packaging
1 tablet (1 tablet/PTP packaging X 1)
Approval status
Active

MFDS item code 201003164 · Approved 2010.04.29 · Insurance code 653701880

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women
Who takes it
Adults · Children
Adult dose
1. Adults : Administer 150 mg of risedronate sodium orally once monthly. 2. Older adults : No dosage adjustment is necessary in older adults (over 60 years) because the bioavailability and pharmacodynamics of this medicine are similar to those in younger people. 4. Patients with renal impairment : No dosage adjustment is necessary in patients with a creatinine clearance of 30 mL/min or more. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30 mL/min. ○ Food interferes with the absorption of this medicine. For adequate absorption, take it at least 30 minutes before the first food or beverage other than water of the day. To help this medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking it with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take this medicine on the scheduled dosing day, follow these instructions. - If the next scheduled dosing day is 7 days or more away, take 1 tablet the morning after remembering. Resume taking the next dose on the originally scheduled dosing day. Do not take more than 1 tablet of this medicine within 7 days. - If the next scheduled dosing day is within 7 days, wait until the originally scheduled dosing day and then take 1 tablet of this medicine.
Child dose
3. Children : The safety and efficacy of this medicine in children under 18 years of age have not been established.

Ingredients

Manufacturer
Samnam Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women

  • Osteoporosis
View approved original text

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women.

How to take

Adult dose

1. Adults : Administer 150 mg of risedronate sodium orally once monthly. 2. Older adults : No dosage adjustment is necessary in older adults (over 60 years) because the bioavailability and pharmacodynamics of this medicine are similar to those in younger people. 4. Patients with renal impairment : No dosage adjustment is necessary in patients with a creatinine clearance of 30 mL/min or more. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30 mL/min. ○ Food interferes with the absorption of this medicine. For adequate absorption, take it at least 30 minutes before the first food or beverage other than water of the day. To help this medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking it with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take this medicine on the scheduled dosing day, follow these instructions. - If the next scheduled dosing day is 7 days or more away, take 1 tablet the morning after remembering. Resume taking the next dose on the originally scheduled dosing day. Do not take more than 1 tablet of this medicine within 7 days. - If the next scheduled dosing day is within 7 days, wait until the originally scheduled dosing day and then take 1 tablet of this medicine.

Child dose

3. Children : The safety and efficacy of this medicine in children under 18 years of age have not been established.

Precautions

This medication may cause gastrointestinal irritation; therefore, patients with diseases of the esophagus or stomach should take special care when using it. After taking the medication, it should be taken with a sufficient amount of water, and the patient should not lie down for at least 30 minutes. If any abnormal symptoms occur in the esophagus, the medication should be stopped immediately and the patient should consult a doctor. This medication should not be used in patients with certain esophageal diseases, hypocalcemia, severe renal impairment, or in women who are pregnant or breastfeeding. Additionally, caution is advised for patients with lactose intolerance. This medication may hinder the absorption of other medications containing calcium, magnesium, or iron, so an interval should be taken between dosing. Rarely, serious side effects such as bone or muscle pain and jaw osteonecrosis may occur with long-term use; any symptoms should be discussed with healthcare professionals. Adequate intake of calcium and vitamin D, along with weight-bearing exercises and maintenance of a healthy lifestyle, will aid in treatment. Women who are pregnant or breastfeeding should avoid taking this medication, and its safety and effectiveness have not been established for children under the age of 18. In case of overdose, symptoms of hypocalcemia may appear, so the healthcare provider should be notified immediately for appropriate treatment. This medication should be stored out of the reach of children and should not be transferred to other containers.

Side effects

  • Esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • esophageal perforation
  • gastric ulcer
  • duodenal ulcer
  • dyspepsia
  • diarrhea
  • abdominal pain
Show 43 more
  • nausea
  • arthralgia
  • arthritis
  • fracture
  • joint abnormalities
  • myalgia
  • bone pain
  • dizziness
  • depression
  • insomnia
  • bronchitis
  • sinusitis
  • rhinitis
  • pharyngitis
  • increased cough
  • rash
  • cataract
  • urinary tract infection
  • mucous membrane syndrome
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • angioedema
  • blistering
  • skin reactions
  • external auditory canal osteonecrosis
  • iritis
  • uveitis
  • liver dysfunction
  • jaundice
  • loss of appetite
  • asthenia
  • heartburn
  • epigastric pain
  • chest discomfort
  • palpitations
  • increased sweating
  • facial flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever
  • eye pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that prevents air from entering, and it is recommended to keep it at room temperature between 1°C and 30°C. Storing it this way will help maintain the effectiveness of the medication over time.

Appearance and packaging

Appearance

Bright blue oval film-coated tablet

Package unit

1 tablet (1 tablet/PTP packaging X 1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.